|
NZ580327A
(en)
*
|
2007-04-03 |
2012-02-24 |
Array Biopharma Inc |
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
|
|
EP2225252B1
(en)
|
2007-11-30 |
2012-06-27 |
Novartis AG |
C2-c5-alkyl-imidazole-bisphosphonates
|
|
US8987251B2
(en)
|
2008-08-19 |
2015-03-24 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
WO2010022081A1
(en)
|
2008-08-19 |
2010-02-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as pim kinase inhibitors
|
|
US8895550B2
(en)
|
2008-08-19 |
2014-11-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
TWI496779B
(zh)
*
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為ｐｉｍ激酶抑制劑之三唑吡啶化合物
|
|
JP5781943B2
(ja)
|
2009-01-21 |
2015-09-24 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
炎症性疾患、自己免疫疾患または増殖性疾患の治療に有用なｎ２−（３−ピリジルまたはフェニル）−ｎ４−（４−ピペリジル）−２，４−ピリミジンジアミン誘導体
|
|
AU2010255422B2
(en)
|
2009-06-05 |
2014-04-10 |
Pfizer Inc. |
1- ( piperidin-4-yl) -pyrazole derivatives as GPR 119 modulators
|
|
AU2010311511B2
(en)
|
2009-10-30 |
2014-07-17 |
Janssen Pharmaceutica Nv |
Imidazo[1,2-b]pyridazine derivatives and their use as PDE10 inhibitors
|
|
EP2332917B1
(en)
*
|
2009-11-11 |
2012-08-01 |
Sygnis Bioscience GmbH & Co. KG |
Compounds for PIM kinase inhibition and for treating malignancy
|
|
FR2952934B1
(fr)
*
|
2009-11-23 |
2012-06-22 |
Sanofi Aventis |
Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
|
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
|
US9187435B2
(en)
|
2010-11-17 |
2015-11-17 |
Actelion Pharmaceuticals Ltd. |
Bridged Spiro[2.4]heptane ester derivatives
|
|
HRP20160134T1
(hr)
*
|
2011-02-25 |
2016-04-08 |
Array Biopharma, Inc. |
Spojevi triazolopiridina kao inhibitori pim kinaze
|
|
EP2524915A1
(en)
|
2011-05-20 |
2012-11-21 |
Sanofi |
2-Amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
|
|
MX344600B
(es)
|
2011-06-27 |
2016-12-20 |
Janssen Pharmaceutica Nv |
Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxalina.
|
|
WO2013005057A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
|
WO2013007768A1
(en)
|
2011-07-13 |
2013-01-17 |
F. Hoffmann-La Roche Ag |
Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors
|
|
ES2586527T3
(es)
|
2011-10-14 |
2016-10-17 |
Ambit Biosciences Corporation |
Compuestos heterocíclicos y uso de los mismos como moduladores del receptor de tirosina quinasas de tipo III
|
|
MA37618B1
(fr)
|
2012-05-16 |
2017-08-31 |
Actelion Pharmaceuticals Ltd |
Dérivés pontés fluorés de spiro[2.4]heptane en tant qu'agonistes de récepteur alx
|
|
AU2013283426B2
(en)
|
2012-06-26 |
2018-02-22 |
Janssen Pharmaceutica Nv |
Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological or metabolic disorders
|
|
CN104411314B
(zh)
|
2012-07-09 |
2017-10-20 |
詹森药业有限公司 |
磷酸二酯酶10的抑制剂
|
|
CA2886187C
(en)
*
|
2012-09-28 |
2020-04-14 |
Vanderbilt University |
Fused heterocyclic compounds as selective bmp inhibitors
|
|
ES2649156T3
(es)
|
2013-01-14 |
2018-01-10 |
Incyte Holdings Corporation |
Compuestos bicíclicos de carboxamida aromática útiles como inhibidores de quinasas Pim
|
|
ES2941292T3
(es)
|
2013-01-15 |
2023-05-19 |
Incyte Holdings Corp |
Tiazolecarboxamidas y compuestos de piridinecarboxamida útiles como inhibidores de PIM quinasa
|
|
AR097431A1
(es)
|
2013-08-23 |
2016-03-16 |
Incyte Corp |
Compuestos de carboxamida de furo y tienopiridina útiles como inhibidores de quinasas pim
|
|
US9822124B2
(en)
|
2014-07-14 |
2017-11-21 |
Incyte Corporation |
Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
|
|
US9580418B2
(en)
|
2014-07-14 |
2017-02-28 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
|
CN104597194B
(zh)
*
|
2015-01-15 |
2016-07-06 |
武汉轻工大学 |
3-氯-1，2-丙二醇的高效液相色谱-荧光检测方法
|
|
WO2016196244A1
(en)
|
2015-05-29 |
2016-12-08 |
Incyte Corporation |
Pyridineamine compounds useful as pim kinase inhibitors
|
|
AR105967A1
(es)
|
2015-09-09 |
2017-11-29 |
Incyte Corp |
Sales de un inhibidor de pim quinasa
|
|
US9920032B2
(en)
|
2015-10-02 |
2018-03-20 |
Incyte Corporation |
Heterocyclic compounds useful as pim kinase inhibitors
|
|
SG11202002032SA
(en)
|
2017-09-22 |
2020-04-29 |
Jubilant Epipad LLC |
Heterocyclic compounds as pad inhibitors
|
|
AU2018352142B2
(en)
|
2017-10-18 |
2022-08-25 |
Jubilant Epipad LLC |
Imidazo-pyridine compounds as PAD inhibitors
|
|
KR20200085836A
(ko)
|
2017-11-06 |
2020-07-15 |
주빌런트 프로델 엘엘씨 |
Pd1/pd-l1 활성화 억제제로서의 피리미딘 유도체
|
|
AU2018372211B2
(en)
|
2017-11-24 |
2023-02-02 |
Jubilant Episcribe LLC, |
Heterocyclic compounds as PRMT5 inhibitors
|
|
WO2019113487A1
(en)
|
2017-12-08 |
2019-06-13 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
AU2019234185B2
(en)
|
2018-03-13 |
2024-08-01 |
Jubilant Prodel LLC. |
Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation
|
|
US10745400B2
(en)
|
2018-03-14 |
2020-08-18 |
Vanderbuilt University |
Inhibition of BMP signaling, compounds, compositions and uses thereof
|
|
CN110833556A
(zh)
*
|
2018-08-15 |
2020-02-25 |
广西梧州制药（集团）股份有限公司 |
吡唑并嘧啶衍生物在治疗肝纤维化的用途
|
|
US20240025892A1
(en)
*
|
2020-08-05 |
2024-01-25 |
The General Hospital Corporation |
Salt inducible kinase inhibitors
|